Publication | Closed Access

Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial

Rheumatoid DisorderRheumatologyAutoimmune DiseaseRheumatic DiseasesPediatricsOsteoarthritisInflammatory Rheumatic DiseasePaediatric RheumatologyMedicineRheumatoid ArthritisSystemic Juvenile Idiopathic Arthritis